Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck

NCT05751512 2023-03-02

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Phase 3 Unknown

180 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02661152 2021-04-13

DAHANCA30

Phase 3 Unknown

1,252 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia

NCT04780750 2021-03-03

Concurent Chemoradiotherapy in Head and Neck Cancers

Phase 3 Unknown

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04146402 2020-02-05

SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Phase 3 Unknown

330 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03855384 2019-10-30

Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

Phase 3 Unknown

334 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00999700 2017-09-05

INTERCEPTOR

Phase 3 Unknown

282 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00002659 2013-12-19

Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Phase 3 Unknown

120 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00720070 2013-08-26

PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer

Phase 3 Unknown

560 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT00336947 2013-05-15

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Phase 3 Unknown

500 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01124409 2011-06-23

Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.

Phase 3 Unknown

41 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT00935675 2009-09-02

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Phase 3 Unknown

100 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma

NCT00041613 2008-04-01

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

Phase 3 Unknown

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Clinical Trials

Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

DAHANCA30

Concurent Chemoradiotherapy in Head and Neck Cancers

SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

INTERCEPTOR

Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer

PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate